MASLD-Related HCC-Update on Pathogenesis and Current Treatment Options

被引：11

作者：

Leyh, Catherine ^{[1
]}

Coombes, Jason D. ^{[2
]}

Schmidt, Hartmut H. ^{[3
]}

Canbay, Ali ^{[4
]}

Manka, Paul P. ^{[4
]}

Best, Jan ^{[3
]}

机构：

[1] Heinrich Heine Univ Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, Univ Hosp Dusseldorf, Med Fac, D-40225 Dusseldorf, Germany

[2] St Louis Univ, Div Gastroenterol & Hepatol, Internal Med, Sch Med, St Louis, MO 63104 USA

[3] Univ Duisburg Essen, Med Fac, Dept Gastroenterol Hepatol & Transplant Med, D-45147 Essen, Germany

[4] Ruhr Univ Bochum, Univ Hosp Knappschaftskrankenhaus Bochum, Dept Internal Med, D-44801 Bochum, Germany

来源：

JOURNAL OF PERSONALIZED MEDICINE | 2024年 / 14卷 / 04期

关键词：

hepatocellular carcinoma; HCC; MASLD; MASH; NAFLD; NASH; biomarker; intestinal microbiota; FATTY LIVER-DISEASE; UNRESECTABLE HEPATOCELLULAR-CARCINOMA; ATEZOLIZUMAB PLUS BEVACIZUMAB; TRANSPLANTATION; SORAFENIB; CANCER; OBESITY; RISK; CABOZANTINIB; METAANALYSIS;

D O I：

10.3390/jpm14040370

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Hepatocellular carcinoma (HCC) is a common complication of chronic liver diseases and remains a relevant cause of cancer-related mortality worldwide. The global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) as a risk factor for hepatocarcinogenesis is on the rise. Early detection of HCC has been crucial in improving the survival outcomes of patients with metabolic dysfunction-associated steatohepatitis (MASH), even in the absence of cirrhosis. Understanding how hepatocarcinogenesis develops in MASH is increasingly becoming a current research focus. Additive risk factors such as type 2 diabetes mellitus (T2DM), genetic polymorphisms, and intestinal microbiota may have specific impacts. Pathophysiological and epidemiological associations between MASH and HCC will be discussed in this review. We will additionally review the available tumor therapies concerning their efficacy in MASH-associated HCC treatment.

引用

页数：16

共 92 条

[1] Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma [J].

Abou-Alfa, G. K. ;

Meyer, T. ;

Cheng, A. -L. ;

El-Khoueiry, A. B. ;

Rimassa, L. ;

Ryoo, B. -Y. ;

Cicin, I. ;

Merle, P. ;

Chen, Y. H. ;

Park, J. -W. ;

Blanc, J. -F. ;

Bolondi, L. ;

Klumpen, H. -J. ;

Chan, S. L. ;

Zagonel, V. ;

Pressiani, T. ;

Ryu, M. -H. ;

Venook, A. P. ;

Hessel, C. ;

Borgman-Hagey, A. E. ;

Schwab, G. ;

Kelley, R. K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01) :54-63

[2]

Abou-Alfa GK, 2022, NEJM EVID, V1, DOI 10.1056/EVIDoa2100070

[3] A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease [J].

Abul-Husn, N. S. ;

Cheng, X. ;

Li, A. H. ;

Xin, Y. ;

Schurmann, C. ;

Stevis, P. ;

Liu, Y. ;

Kozlitina, J. ;

Stender, S. ;

Wood, G. C. ;

Stepanchick, A. N. ;

Still, M. D. ;

McCarthy, S. ;

O'Dushlaine, C. ;

Packer, J. S. ;

Balasubramanian, S. ;

Gosalia, N. ;

Esopi, D. ;

Kim, S. Y. ;

Mukherjee, S. ;

Lopez, A. E. ;

Fuller, E. D. ;

Penn, J. ;

Chu, X. ;

Luo, J. Z. ;

Mirshahi, U. L. ;

Carey, D. J. ;

Still, C. D. ;

Feldman, M. D. ;

Small, A. ;

Damrauer, S. M. ;

Rader, D. J. ;

Zambrowicz, B. ;

Olson, W. ;

Murphy, A. J. ;

Borecki, I. B. ;

Shuldiner, A. R. ;

Reid, J. G. ;

Overton, J. D. ;

Yancopoulos, G. D. ;

Hobbs, H. H. ;

Cohen, J. C. ;

Gottesman, O. ;

Teslovich, T. M. ;

Baras, A. ;

Mirshahi, T. ;

Gromada, J. ;

Dewey, F. E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (12) :1096-1106

[4] From NASH to HCC: current concepts and future challenges [J].

Anstee, Quentin M. ;

Reeves, Helen L. ;

Kotsiliti, Elena ;

Govaere, Olivier ;

Heikenwalder, Mathias .

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (07) :411-428

[5] The Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Nonalcoholic Steatohepatitis [J].

Ascha, Mustafa S. ;

Hanouneh, Ibrahim A. ;

Lopez, Rocio ;

Tamimi, Tarek Abu-Rajab ;

Feldstein, Ariel F. ;

Zein, Nizar N. .

HEPATOLOGY, 2010, 51 (06) :1972-1978

[6] Editorial: NAFLD-related hepatocellular carcinoma - increasing or not? With or without cirrhosis? [J].

Balakrishnan, M. ;

El-Serag, H. B. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (03) :437-438

[7] Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis [J].

Bechmann, Lars P. ;

Kocabayoglu, Peri ;

Sowa, Jan-Peter ;

Sydor, Svenja ;

Best, Jan ;

Schlattjan, Martin ;

Beilfuss, Anja ;

Schmitt, Johannes ;

Hannivoort, Rebekka A. ;

Kilicarslan, Alpaslan ;

Rust, Christian ;

Berr, Frieder ;

Tschopp, Oliver ;

Gerken, Guido ;

Friedman, Scott L. ;

Geier, Andreas ;

Canbay, Ali .

HEPATOLOGY, 2013, 57 (04) :1394-1406

[8] GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis [J].

Best, Jan ;

Bechmann, Lars P. ;

Sowa, Jan-Peter ;

Sydor, Svenja ;

Dechene, Alexander ;

Pflanz, Kristina ;

Bedreli, Sotiria ;

Schotten, Clemens ;

Geier, Andreas ;

Berg, Thomas ;

Fischer, Janett ;

Vogel, Arndt ;

Bantel, Heike ;

Weinmann, Arndt ;

Schattenberg, Joern M. ;

Huber, Yvonne ;

Wege, Henning ;

von Felden, Johann ;

Schulze, Kornelius ;

Bettinger, Dominik ;

Thimme, Robert ;

Sinner, Friedrich ;

Schuette, Kerstin ;

Weiss, Karl Heinz ;

Toyoda, Hidenori ;

Yasuda, Satoshi ;

Kumada, Takashi ;

Berhane, Sarah ;

Wichert, Marc ;

Heider, Dominik ;

Gerken, Guido ;

Johnson, Philip ;

Canbay, Ali .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (03) :728-+

[9]

Brenner DA, 2015, J CLIN GASTROENTEROL, V49, pS25, DOI 10.1097/MCG.0000000000000391

[10] Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial [J].

Bruix, Jordi ;

Qin, Shukui ;

Merle, Philippe ;

Granito, Alessandro ;

Huang, Yi-Hsiang ;

Bodoky, Gyrogy ;

Pracht, Marc ;

Yokosuka, Osamu ;

Rosmorduc, Olivier ;

Breder, Valeriy ;

Gerolami, Rene ;

Masi, Gianluca ;

Ross, Paul J. ;

Song, Tianqiang ;

Bronowicki, Jean-Pierre ;

Ollivier-Hourmand, Isabelle ;

Kudo, Masatoshi ;

Cheng, Ann-Lii ;

Llovet, Josep M. ;

Finn, Richard S. ;

LeBerre, Marie-Aude ;

Baumhauer, Annette ;

Meinhardt, Gerold ;

Han, Guohong .

LANCET, 2017, 389 (10064) :56-66

← 1 2 3 4 5 6 7 8 9 10 →